Geneva Statement on Heritable Human Genome Editing: The Need for Course Correction
By Roberto Andorno, Françoise Baylis, Marcy Darnovsky, Donna Dickenson, Hille Haker, Katie Hasson, Leah Lowthorp, et al.,
Trends in Biotechnology
| 01. 31. 2020
Heritable Human Genome Editing: Nearing a Critical Juncture
The impending decision about whether to develop and use heritable human genome modification carries high stakes for our shared future. Deciding to proceed with altering the genes of future children and generations would mean abandoning the restraint urged by the United Nations (UN) General Assembly’s formal endorsement of the Universal Declaration on the Human Genome and Human Rights [1] and required by the laws and regulations of more than 50 nations (F. Baylis et al., in preparation), including 29 that have ratified the Oviedo Convention, a binding international treaty [2]. Policymakers put these prohibitions in place to protect human rights and the fundamental equality of all people; to safeguard the physical, psychological, and social wellbeing of children; and to avert the emergence of a new eugenics.
Despite the persistence of these fundamental and widely shared concerns, a small but vocal group of scientists and bioethicists now endorse moving forward with heritable human genome editingi,ii [3]. They have taken it as their task...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...